AIDS 2018

Each year, more than 15,000 global health professionals, advocates, and policymakers come together for the International AIDS Conference to connect and inform the future of AIDS and HIV prevention, management, and cure through the lens of innovation, science, and advocacy. Follow our coverage to learn what the world’s largest global health gathering mean for our industry’s professionals.

Stulwhayvoh6k3ihdzo3jun1w t3enaqccwyxmtoxcbejz 0ldagaldpbv9f6saiazsfog9yvt5qhwubon5iohylwu2njqs1hecpglo0dzjmzp3fbpcpkjg0cx lqat02j8iqtf9

Ebola spreads, Oxfam's verdict, and PEPFAR cuts: This week in development

PEPFAR funding: Taking stock of the latest changes

To help understand PEPFAR's evolving business model, Devex digs into the available data to uncover key issues and trends shaping PEPFAR activities in Nigeria and Zambia.

Opinion: The 'global gag rule' hits PEPFAR implementers, study shows

The expanded gag rule has impeded the ability of PEPFAR implementing partners to provide full sexual and reproductive health services, disrupting the provision of contraception and HIV services.

Opinion: The world must invest in the fight against HIV, TB, malaria

The leader of the World Health Organization Tedros Adhanom Ghebreyesus makes the case for a strong, well-funded Global Fund to Fight AIDS, Tuberculosis and Malaria.

The future of UNAIDS

The U.N. AIDS agency is battling a leadership crisis following a report on sexual abuse, bullying, and abuse of power at the institution. It is unclear how it will recover.

Q&A: Why knowledge is power when it comes to HIV/AIDS

Ahead of World AIDS Day, Abbott’s Rachel O’Shea explains why people living with HIV/AIDS should "know their numbers," and how they can be enabled to do so even in remote and rural locations.

High-level support for PEPFAR, with budget cut proposals looming

As U.S. Congress reauthorized the President's Emergency Plan for AIDS Relief, Trump administration officials voiced support for PEPFAR and announced new funding commitments. That doesn't mean they won't try again to slash the initiative's budget next year.

At AIDS 2018, a strong push for HIV self-testing. But is everyone on board?

HIV self-testing received an additional boost at the just-concluded AIDS 2018 conference in Amsterdam. With the traditional approach to testing having attained its "limits," especially in reaching high-risk populations, experts and advocates argue backing self-testing is worth the level of investment.

Long Story Short #23: Inside the global HIV/AIDS response

Youth. Integration. Prevention. Live from AIDS 2018, reporter Sophie Edwards and youth advocate Mercy Ngulube discuss the future of the HIV/AIDS response.

AIDS 2018 told the story of a global health crisis

Underlying conversations at the 22nd International AIDS Conference last week was a growing realization that the fight against HIV/AIDS is in crisis, with 1.8 million new infections in 2017, spikes in key populations, and falling funding. Devex rounds up the key takeaways about the biggest concerns, and what can be done.

Launch of $1.2B coalition to expand HIV services for men

Around the world, men are less likely to receive diagnoses and treatments for HIV/AIDS than women and are more likely to die from the disease. A new partnership of major donors, NGOs, and pharmaceuticals aims to overcome the barriers that prevent men from accessing help.

UNAIDS chief confronted by anti-harassment protestors on stage in Amsterdam

Campaigners hijacked the opening of the 22nd International AIDS Conference to protest the presence of UNAIDS Executive Director Michel Sidibé, who has been criticized for his response to a sexual harassment scandal.

Opinion: The global HIV response is neglecting people who use drugs

People who inject drugs are more than 20 times more likely to contract the virus than the general public — they are also one of the most marginalized groups. Naomi Burke-Shyne, deputy director of Harm Reduction International, explains.

Q&A: Diagnostic tools as the answer to HIV and AIDS

At this week’s International AIDS Conference in Amsterdam, global health care company Abbott rolls out a new point-of-care diagnostic test for HIV/AIDS designed to work in remote and under-resourced settings. The organization's Dr. Kuku Appiah tells Devex how this has the potential to accelerate treatment, prevent transmission, monitor the emergence of drug resistance, and overall, contribute to the UNAIDS 90-90-90 goals.

The 'end of AIDS' is not even nearly in sight, experts warn

Leading experts warn against complacency in the fight against HIV and AIDS, as new data published ahead of the 22nd International AIDS Conference next week shows minimal progress.

Q&A: Chip Lyons on PEPFAR's 'great leap into the unknown' of controlling HIV and AIDS

On PEPFAR's 15th anniversary, Devex spoke to Chip Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, about how the initiative has transformed U.S. global health, and where it goes from here.

Q&A: How Rwanda focused PEPFAR funds on 'people-centric, not disease-centric' care

As PEPFAR marks its 15th anniversary, Devex spoke to Agnes Binagwaho about the program, its impacts in Rwanda, and what’s needed both in the fight against HIV and AIDS and to improve health systems.

PEPFAR chief questions US approach to supply chain technical assistance

Speaking at a congressional hearing on USAID's $9.5 billion global health supply chain project, U.S. Ambassador Deborah Birx raised questions about how effectively the $3 billion spent on technical assistance since 2009 has been deployed.

World at risk of losing control of HIV and AIDS epidemic, PEPFAR architect says

The HIV and AIDS epidemic could become uncontained if current funding trends continue, warned one of the founding architects of the United States President’s Emergency Plan for AIDS Relief.

Powered by



See more jobs